The incidence of acne varies by transgender status, in a multicenter cohort study of transgender individuals starting hormone ...

Denifanstat met all endpoints in a Phase 3 acne trial and showed favorable tolerability. Sagimet also launched a Phase 1 trial for TVB-3567. Sagimet Biosciences announced that its oral fatty acid ...

When you buy through links on our articles, Future and its syndication partners may earn a commission. In a clinical trial, scientists are investigating whether a vaccine could treat patients with ...

Please provide your email address to receive an email when new articles are posted on . Denifanstat, a fatty acid synthase inhibitor, was effective in the treatment of moderate to severe acne vulgaris ...

Acne sufferers may benefit from following a Mediterranean diet and taking omega-3 fatty acid supplements derived from algae, a new study out of Germany finds. The research, published Wednesday in the ...

Acne incidence rose sharply in transmasculine transgender individuals after testosterone, with moderate to severe cases also increasing. Clinicians should monitor closely, especially in the first year ...

Clascoterone cream 1% plus adapalene gel 0.3% offers an effective, well-tolerated topical option for moderate to severe acne, ...

Final patient visit marks key milestone for Biofrontera, with top-line results expected Q1 2026 Company plans FDA discussion in Q3 2026 to advance Phase 3 program and potential label expansion More ...

Oral FASN inhibitors offer a novel mechanism of action for the potential treatment of moderate to severe acne Sagimet initiated first-in-human Phase 1 clinical trial of a second FASN inhibitor, ...

The treatment of acne ( Table I) [1,2,3,4,5,6] is based upon its severity (mild, moderate, severe) and the type(s) of lesion(s) present (noninflammatory, inflammatory, mixed). In general, the ...

Following a Mediterranean diet and taking an over-the-counter supplement can help reduce acne and improve quality of life, a new study shows. The research, published Wednesday in the Journal of ...